Check out our comprehensive whitepaper, "Innovation and the Black Swan: the Imperative of AI-enabled clinical research," for an in-depth look at how embracing AI-enabled tools and technologies is...
PROPHARMA ANNOUNCES ACQUISITION OF UK-BASED DIGITAL LAB CONSULTING TO EXPAND R&D CAPABILITIES AND ACCELERATE PRODUCT DEVELOPMENT RALEIGH, NC, January 25, 2023: ProPharma Group (ProPharma) the...
Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the acquisition of M Squared Associates (M2), an industry leading clinical, regulatory and quality consulting firm...
ProPharma Group Announces the Acquisition of Pharmica Consulting: ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Pharmica Consulting, a life science...
ProPharma Group, a portfolio company of Odyssey Investment Partners, is the global, independent, single-source provider of regulatory, clinical and compliance services serving pharmaceutical,...
ProPharma Group Announces the Acquisition of iSafety Systems: ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of iSafety Systems. Headquartered in...
NDA Partners President Earle Martin announced today that Cristina Giachetti, PhD, former Deputy Director of Diagnostics at the Bill and Melinda Gates Foundation, has joined the firm as an Expert...